Tag: Sayre Therapeutics
Sayre Therapeutics to market the oncology products of Navidea in India
Sayre Therapeutics has entered into an exclusive license and distribution agreement with Navidea Biopharmaceuticals to market 'Tc 99m Tilmanocept' a radiopharma agent in India..............
Sayre Therapeutics to market oncology product of Spain’s GP Pharm
Spanish firm, GP Pharm will supply the prostate cancer drug, LUTRATE® to Bangalore-based Sayre Therapeutics on an exclusive basis from its manufacturing facility in Barcelona.........